Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Liquidia CorpLQDA · Entity 1860 | Chief Commercial Officer | October 09, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Liquidia Corp
Report date October 09, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 181,487 |
Last balance in matching sequence
After 2026-10-12 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-10-09 · Exercise / conversion · Acquired 3,108 · Balance 185,992 F2: On January 11, 2024, the Reporting Person was granted 49,723 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 34,185 have vested as of the date of this Form 4. F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 15,538 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 39,222 unvested RSUs of the 69,729 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,049 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Row 2 · 2026-10-09 · Exercise / conversion · Acquired 4,358 · Balance 190,350 F4: On January 11, 2025, the Reporting Person was granted 69,729 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 30,507 have vested as of the date of this Form 4. F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 15,538 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 39,222 unvested RSUs of the 69,729 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,049 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Row 3 · 2026-10-12 · Sale · Disposed 8,863 · Balance 181,487 F5: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 15,538 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 39,222 unvested RSUs of the 69,729 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,049 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,538 |
Reported balance
After 2026-10-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-09 · Exercise / conversion · Disposed 3,108 · Balance 15,538 F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 39,222 |
Reported balance
After 2026-10-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-09 · Exercise / conversion · Disposed 4,358 · Balance 39,222 F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
F2: On January 11, 2024, the Reporting Person was granted 49,723 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 34,185 have vested as of the date of this Form 4.
F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 15,538 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 39,222 unvested RSUs of the 69,729 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,049 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
F4: On January 11, 2025, the Reporting Person was granted 69,729 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 30,507 have vested as of the date of this Form 4.
F5: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
F6: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2022 Filed Sep 2, 2022 00:41 UTC | Liquidia Corp LQDA · Entity 1860 | PurchaseCommon Stock | 2,160 | $4.90 | $10,593.72 |
DisclosureSEC source: 0001104659-22-097132 · tm2225015-4_4seq1.xml · nonDerivative · entry 1 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,810 Read SEC document |
| August 31, 2022 Filed Apr 10, 2023 20:33 UTC Amendment | Liquidia Corp LQDA · Entity 1860 | GrantCommon Stock | 2,160 | $4.90 | $10,593.72 |
DisclosureSEC source: 0001104659-23-043617 · tm2311744-5_4aseq.xml · nonDerivative · entry 1 Moomaw Scott · CIK 0001832592 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,810 F1 · shares: This amendment is being filed solely to add this footnote 1 and to correct the transaction code in box 3 above. These shares of common stock were acquired on August 31, 2022 through the Liquidia Corporation 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 22:37 UTC | Liquidia Corp LQDA · Entity 1860 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001104659-22-084860 · tm2222301-2_4seq1.xml · derivative · entry 1 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-07-28 F1 · derivative.exercise_date: The options will vest ratably on a monthly basis over four years with the first vesting date to occur on August 31, 2022, and on the last day of each month thereafter. Read SEC document |
| January 16, 2022 Filed Jan 19, 2022 21:34 UTC | Liquidia Corp LQDA · Entity 1860 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $6.25 | $0.00 |
DisclosureSEC source: 0001104659-22-005471 · tm221559-4_4seq1.xml · derivative · entry 2 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-01-16 F3 · derivative.exercise_date: The options will vest ratably on a monthly basis over four years with the first vesting date to occur on February 28, 2022 and on the last day of each month thereafter. Read SEC document |
| January 16, 2022 Filed Jan 19, 2022 21:34 UTC | Liquidia Corp LQDA · Entity 1860 | GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-005471 · tm221559-4_4seq1.xml · derivative · entry 1 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: 25% of the RSUs shall vest on February 28, 2023 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter. F2 · derivative.expiration_date: 25% of the RSUs shall vest on February 28, 2023 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 00:11 UTC | Liquidia Corp LQDA · Entity 1860 | GrantPerformance Stock Units · Derivative | 7,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-138300 · tm2132597-4_4seq1.xml · derivative · entry 2 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,650 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit (PSU) converts into one share of common stock of the Issuer. F2 · derivative.exercise_date: On January 19, 2021, the reporting person was granted 7,650 PSUs, vesting in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861. F2 · derivative.expiration_date: On January 19, 2021, the reporting person was granted 7,650 PSUs, vesting in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 00:11 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 7,650 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-138300 · tm2132597-4_4seq1.xml · nonDerivative · entry 1 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit (PSU) converts into one share of common stock of the Issuer. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 22:13 UTC | Liquidia Corp LQDA · Entity 1860 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001104659-21-095510 · tm2123135-5_4seq1.xml · derivative · entry 1 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-07-21 F1 · derivative.exercise_date: The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:22 UTC | Liquidia Corp LQDA · Entity 1860 | GrantPerformance Stock Units · Derivative | 7,650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-005983 · tm213622d2_4.xml · derivative · entry 2 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 7,650 shares Expires not disclosed F2 · derivative.exercise_date: The performance stock units (PSUs) vest in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861. Each PSU represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.expiration_date: The performance stock units (PSUs) vest in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861. Each PSU represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:22 UTC | Liquidia Corp LQDA · Entity 1860 | GrantEmployee Stock Option (right to buy) · Derivative | 15,300 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-21-005983 · tm213622d2_4.xml · derivative · entry 1 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 Underlying: Common Stock · 15,300 shares Expires 2031-01-19 F1 · derivative.exercise_date: The option vests in equal monthly installments over a four-year period, becoming fully vested on January 19, 2025. Read SEC document |
| November 19, 2020 Filed Nov 19, 2020 23:15 UTC | Liquidia Corp LQDA · Entity 1860 | GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-127452 · a4.xml · derivative · entry 1 Moomaw Scott · CIK 0001832592 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on November 19, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.